AbbVie Inc.
ABBVSEC CIK 1551152Price charts ↗
Writing the earnings story…
Financials
Revenue+17.7% YoY
$8.24B
Mar '17Jun '17Sep '17Mar '18Jun '18Sep '18
Net Income+68.4% YoY
$2.75B
Mar '17Jun '17Sep '17Mar '18Jun '18Sep '18
EPS (diluted)+79.2% YoY
$1.81
Mar '17Jun '17Sep '17Mar '18Jun '18Sep '18
Gross Margin+1.1% YoY
77.7%
Mar '17Jun '17Sep '17Mar '18Jun '18Sep '18
| Quarter ending | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2018 | $8.24B | $2.75B | $1.81 |
| Jun 2018 | $8.28B | $1.98B | $1.26 |
| Mar 2018 | $7.93B | $2.78B | $1.74 |
| Sep 2017 | $7.00B | $1.63B | $1.01 |
| Jun 2017 | $6.94B | $1.92B | $1.19 |
| Mar 2017 | $6.54B | $1.71B | $1.06 |
Annual revenue
FY21FY22FY23FY24FY25
Source filings
Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.
Quarterly report (10-Q)Filed 2026-05-08 · period ending 2026-03-31Open ↗Annual report (10-K)Filed 2026-02-20 · period ending 2025-12-31Open ↗Quarterly report (10-Q)Filed 2025-11-04 · period ending 2025-09-30Open ↗Quarterly report (10-Q)Filed 2025-08-04 · period ending 2025-06-30Open ↗Quarterly report (10-Q)Filed 2025-05-09 · period ending 2025-03-31Open ↗Annual report (10-K)Filed 2025-02-14 · period ending 2024-12-31Open ↗Quarterly report (10-Q)Filed 2024-11-04 · period ending 2024-09-30Open ↗Quarterly report (10-Q)Filed 2024-08-07 · period ending 2024-06-30Open ↗
Glossary
- Revenue
- Net income
- EPS
- Gross margin
- Net margin
- Fiscal year
Hover any underlined term for its definition.